China’s National Medical Products Administration (NMPA) has approved four new drugs developed by local biopharma companies, including a first-of-its-kind molecule in blood cancer. Wednesday, Chinese ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback